11/21
03:36 am
arct
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans [Yahoo! Finance]
Medium
Report
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans [Yahoo! Finance]
11/18
08:00 pm
arct
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference
Medium
Report
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference
11/14
01:00 am
arct
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
Medium
Report
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
11/11
04:17 pm
arct
Arcturus gets FDA clearance for H5N1 avian flu vaccine study [Seeking Alpha]
Medium
Report
Arcturus gets FDA clearance for H5N1 avian flu vaccine study [Seeking Alpha]
11/11
04:01 pm
arct
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
Medium
Report
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
11/9
09:50 am
arct
Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/8
02:48 am
arct
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ... [Yahoo! Finance]
Low
Report
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ... [Yahoo! Finance]
11/7
07:48 pm
arct
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/7
04:55 pm
arct
Arcturus Therapeutics: Q3 Earnings Snapshot [Yahoo! Finance]
Low
Report
Arcturus Therapeutics: Q3 Earnings Snapshot [Yahoo! Finance]
11/7
04:18 pm
arct
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress [Yahoo! Finance]
11/7
04:01 pm
arct
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
Medium
Report
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
11/6
07:41 am
arct
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
11/4
11:43 am
arct
Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect [Yahoo! Finance]
Low
Report
Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect [Yahoo! Finance]
10/31
08:35 pm
arct
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024 [Yahoo! Finance]
Low
Report
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024 [Yahoo! Finance]
10/31
04:01 pm
arct
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024
Low
Report
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024
10/24
07:49 am
arct
Investing in Arcturus Therapeutics Holdings (NASDAQ:ARCT) five years ago would have delivered you a 76% gain [Yahoo! Finance]
Medium
Report
Investing in Arcturus Therapeutics Holdings (NASDAQ:ARCT) five years ago would have delivered you a 76% gain [Yahoo! Finance]
10/1
12:15 pm
arct
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $63.00 price target on the stock.
Medium
Report
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $63.00 price target on the stock.
9/30
08:00 am
arct
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
Medium
Report
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
9/30
08:00 am
arct
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
Medium
Report
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
9/13
09:13 am
arct
New Strong Buy Stocks for September 13th [Yahoo! Finance]
Low
Report
New Strong Buy Stocks for September 13th [Yahoo! Finance]
9/13
08:15 am
arct
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
Medium
Report
Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
9/13
08:00 am
arct
Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
Low
Report
Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
9/9
01:03 pm
arct
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
9/9
11:24 am
arct
RNA Therapeutics Market Size is expected to reach US$ 948 Million by 2031, Report by CoherentMI [Yahoo! Finance]
Low
Report
RNA Therapeutics Market Size is expected to reach US$ 948 Million by 2031, Report by CoherentMI [Yahoo! Finance]
9/3
08:30 am
arct
Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis
Medium
Report
Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis